Polish Survey on the Efficacy of the Hypercholesterolemia Treatment (CEPHEUS)

AstraZeneca

Status: Completed

Conditions: Hypercholesterolemia

Study type: Observational

Funder types: Industry

Identifiers

NCT01243255

NIS-CPL-DUM-2010/1

Details and patient eligibility

About

The purpose of the survey is to evaluate the efficacy of treatment of hypercholesterolemia in Polish patients who are currently on lipid- lowering pharmacological therapy . Efficient treatment is defined as achievement of the LDL cholesterol level goals according to the European Society of Cardiology 2007 guidlines.

Enrollment: 1,500 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients on lipid lowering drug treatment
• Lipid lowering drug treatment lasting at least 3 months
• No lipid lowering drug/dose change for a minimum 6 weeks prior to enrolment to the study

Exclusion criteria

• Lack of patient's signed informed consent form
• Lack of the blood sample taken for lipid profile and glucose within 10 days before or after assessment of the patient

Trial design

1,500 participants in 1 patient group

1

Description:

Patients with hypercholesterolemia on lipid lowering pharmacological treatment